Scientist practitioners
Led by world-renowned experts, we can undertake health preference, health outcomes and health economic studies completely in-house, with bespoke survey development securely running on our own servers. Our team has developed methods and contributed to the development of guidance in the field of health preference research. We are known because of our knowledge of quantitative expertise and our solid track records of publications in scientific journals.
Expertise
Featured publications
PharmacoEconomics. 2016 Oct;34(10):993-1004
doi: https://doi.org/10.1007/s40273-016-0404-1
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N.
Value in Health. 2019 Aug;22(8):931-941
doi: https://doi.org/10.1016/j.jval.2019.02.009
United States Valuation of EQ-5D-5L Health States Using an International Protocol
Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, Oppe M, Boye KS, Chapman RH, Gong CL, Balch A, Busschbach JJV.
PharmacoEconomics. 2020 Jul;38(7):653-663
doi: https://doi.org/10.1007/s40273-020-00909-3
International Valuation Protocol for the EQ-5D-Y-3L
Ramos-Goñi JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, Devlin N.
Expertise
Some of our publications
Value in Health. 2022 Dec 22;S1098-3015(22)04786-6
doi: https://doi.org/10.1016/j.jval.2022.12.012
Cross-attribute level effects models for modelling modified EQ-5D-5L health state values: is less still more?
Yang Z, Rand K, Busschbach J, Luo N.
Journal of the American Pharmacists Association. 2022 Dec 20;S1544-3191(22)00414-9
doi: https://doi.org/10.1016/j.japh.2022.12.018
Pharmacists and Naloxone: Barriers to Dispensing and Effectiveness of an Educational Outreach Program
Hanson KA, Smart MH, Mandava MR, Carkovic E, Aslamy M, Lee TA, Pickard AS.
PLoS One. 2022 Dec 20;17(12):e0279229
doi: https://doi.org/10.1371/journal.pone.0279229
The impact of ultrasound-based antenatal screening strategies to detect vasa praevia in the United Kingdom: An exploratory study using decision analytic modelling methods
Ruban-Fell B, Attilakos G, Haskins-Coulter T, Hyde C, Kusel J, Mackie A, Rivero-Arias O, Thilaganathan B, Thomson N, Visintin C, Marshall J.
Medical Decision Making. 2021 Jul;41(5):584-596
doi: https://doi.org/10.1177/0272989X21999607
Valuing EQ-5D-Y-3L Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
Mott DJ, Shah KK, Ramos-Goñi JM, Devlin NJ, Rivero-Arias O.
Quality of Life Research. 2022 Dec 24
doi: https://doi.org/10.1007/s11136-022-03329-2
Censoring in the time trade-off valuation of worse-than-dead EQ-5D-5L health states: can a time-based willingness-to-accept question be the solution?
Liao M, Rand K, Yang Z, Hsu CN, Lin HW, Luo N.
Pharmacoeconomics. 2022 Dec;40(Suppl 2):139-146
doi: https://doi.org/10.1007/s40273-022-01222-x
Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
Nazari JL, Pickard AS, Gu NY.
Value in Health. 2022 Nov 25;S1098-3015(22)04738-6
doi: https://doi.org/10.1016/j.jval.2022.11.007
The Use of Multicriteria Decision Analysis to Support Decision Making in Healthcare: An Updated Systematic Literature Review
Gongora-Salazar P, Rocks S, Fahr P, Rivero-Arias O, Tsiachristas A.
International Journal of Environmental Research and Public Health. 2022 Jul 5;19(13):8208
doi: https://doi.org/10.3390/ijerph19138208
Health-Related Quality of Life and Perceived Burden of Informal Caregivers of Patients with Rare Diseases in Selected European Countries
Valcárcel-Nazco C, Ramallo-Fariña Y, Linertová R, Ramos-Goñi JM, García-Pérez L, Serrano-Aguilar P.
The European Journal of Health Economics . 2022 Aug;23(6):1007-1014
doi: https://doi.org/10.1007/s10198-021-01411-z
The remarkably frequent use of EQ-5D in non-economic research
Wang A, Rand K, Yang Z, Brooks R, Busschbach J.
Health and Quality of Life Outcomes. 2022 Sep 9;20(1):134
doi: https://doi.org/10.1186/s12955-022-02031-8
EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
Jiang R, Rand K, Kuharic M, Pickard AS.
Pharmacoeconomics. 2022 Dec;40(Suppl 2):129-137
doi: https://doi.org/10.1007/s40273-022-01214-x
Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L
Mott DJ, Devlin NJ, Kreimeier S, Norman R, Shah KK, Rivero-Arias O.
Value in Health. 2022 May;25(5):835-843
doi: https://doi.org/10.1016/j.jval.2021.10.013
Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data
Ramos-Goñi JM, Oppe M, Estévez-Carrillo A, Rivero-Arias O; IMPACT HTA HRQoL Group.
The European Journal of Health Economics . 2022 Sep 2;1-8
doi: https://doi.org/10.1007/s10198-022-01517-y
Completing the time trade-off with respondents who are older, in poorer health or with an immigrant background in an EQ-5D-5L valuation study
Hansen TM, Stavem K, Rand K.
Health and Quality of Life Outcomes. 2022 Jun 16;20(1):97
doi: https://doi.org/10.1186/s12955-022-02002-z
The FACT-8D, a new cancer-specific utility algorithm based on the Functional Assessment of Cancer Therapies-General (FACT-G): a Canadian valuation study
McTaggart-Cowan H, King MT, Norman R, Costa DSJ, Pickard AS, Viney R, Peacock SJ; Canadian MAUCa Team.
Social Science & Medicine. 2022 Dec;314:115428
doi: https://doi.org/10.1016/j.socscimed.2022.115428
Benefits and harms adopted by health economic assessments evaluating antenatal and newborn screening programmes in OECD countries: A systematic review of 336 articles and reports
Png ME, Yang M, Taylor-Phillips S, Ratushnyak S, Roberts N, White A, Hinton L, Boardman F, McNiven A, Fisher J, Thilaganathan B, Oddie S, Slowther AM, Shilton Osborne J, Petrou S, Rivero-Arias O.
Value in Health. 2022 Jul;25(7):1196-1204
doi: https://doi.org/10.1016/j.jval.2022.03.001
Does Changing the Age of a Child to be Considered in 3-Level Version of EQ-5D-Y Discrete Choice Experiment-Based Valuation Studies Affect Health Preferences?
Ramos-Goñi JM, Estévez-Carrillo A, Rivero-Arias O, Rowen D, Mott D, Shah K, Oppe M.
Journal of Allergy and Clinical Immunology. 2022 Nov;150(5):1216-1224
doi: https://doi.org/10.1016/j.jaci.2022.06.006
Normal B-cell ranges in infants: A systematic review and meta-analysis
Borriello F, Pasquarelli N, Law L, Rand K, Raposo C, Wei W, Craveiro L, Derfuss T.
Value in Health. 2022 Apr;25(4):525-533
doi: https://doi.org/10.1016/j.jval.2021.11.1361
Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB
Peasgood T, Mukuria C, Brazier J, Marten O, Kreimeier S, Luo N, Mulhern B, Greiner W, Pickard AS, Augustovski F, Engel L, Gibbons L, Yang Z, Monteiro AL, Kuharic M, Belizan M, Bjørner J.
Value in Health. 2023 Jan;26(1):50-54
doi: https://doi.org/10.1016/j.jval.2022.07.007
Test-Retest Reliability of EQ-5D-Y-3L Best-Worst Scaling Choices of Adolescents and Adults
Xiong X, Dalziel K, Huang L, Rivero-Arias O.
The European Journal of Health Economics . 2023 Feb;24(1):27-38
doi: https://doi.org/10.1007/s10198-022-01449-7
Health state utilities for beta-thalassemia: a time trade-off study
Martin AP, Ferri Grazzi E, Mighiu C, Chevli M, Shah F, Maher L, Shaikh A, Sagar A, Hubberstey H, Franks B, Ramos-Goñi JM, Oppe M, Tang D.
Medical Care. 2022 Jun 1;60(6):462-469
doi: https://doi.org/10.1097/MLR.0000000000001714
Time-Specific Differences in Stated Preferences for Health in the United States
Law EH, Pickard AS, Walton SM, Xie F, Lee TA, Schwartz A.
BMJ Open. 2022 Jun 9;12(6):e062833
doi: https://doi.org/10.1136/bmjopen-2022-062833
Using stated-preferences methods to develop a summary metric to determine successful treatment of children with a surgical condition: a study protocol
Rivero-Arias O, Buckell J, Allin B, Craig BM, Ayman G, Knight M; CSOR Collaborative Group.
The Patient - Patient-Centered Outcomes Research . 2022 Sep;15(5):521-535
doi: https://doi.org/10.1007/s40271-022-00573-z
Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain
Estévez-Carrillo A, Dewilde S, Oppe M, Ramos-Goñi JM.
Quality of Life Research. 2022 Sep;31(9):2763-2774
doi: https://doi.org/10.1007/s11136-022-03143-w
Estimating the EQ-5D-5L value set for the Philippines
Miguel RTD, Rivera AS, Cheng KJG, Rand K, Purba FD, Luo N, Zarsuelo MA, Genuino-Marfori AJ, Florentino-Fariñas I, Guerrero AM, Lam HY.
Pharmacoeconomics. 2022 May;40(5):559-574
doi: https://doi.org/10.1007/s40273-022-01132-y
The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease in England
Chaudhuri KR, Pickard AS, Alobaidi A, Jalundhwala YJ, Kandukuri PL, Bao Y, Sus J, Jones G, Ridley C, Oddsdottir J, Najle-Rahim S, Madin-Warburton M, Xu W, Schrag A.
JAMA. 2022 May 3;327(17):1656-1665
doi: https://doi.org/10.1001/jama.2022.4712
Effect of Self-monitoring of Blood Pressure on Diagnosis of Hypertension During Higher-Risk Pregnancy: The BUMP 1 Randomized Clinical Trial
Tucker KL, Mort S, Yu LM, Campbell H, Rivero-Arias O, Wilson HM, Allen J, Band R, Chisholm A, Crawford C, Dougall G, Engonidou L, Franssen M, Green M, Greenfield S, Hinton L, Hodgkinson J, Lavallee L, Leeson P, McCourt C, Mackillop L, Sandall J, Santos M, Tarassenko L, Velardo C, Yardley L, Chappell LC, McManus RJ; BUMP Investigators.
Value in Health. 2021 Sep;24(9):1350-1359
doi: https://doi.org/10.1016/j.jval.2021.03.019
Comparison of Adult and Adolescent Preferences Toward EQ-5D-Y-3L Health States
Prevolnik Rupel V, Ramos-Goñi JM, Ogorevc M, Kreimeier S, Ludwig K, Greiner W.
BMC Health Services Research.. 2022 Mar 15;22(1):336
doi: https://doi.org/10.1186/s12913-021-07385-1
Stroke unit demand in Norway - present and future estimates
Dahl FA, Barra M, Faiz KW, Ihle-Hansen H, Næss H, Rand K, Rønning OM, Simonsen TB, Thommessen B, Labberton AS.
Value in Health. 2022 Apr;25(4):534-543
doi: https://doi.org/10.1016/j.jval.2022.01.003
A Comparison of a Preliminary Version of the EQ-HWB Short and the 5-Level Version EQ-5D
Monteiro AL, Kuharic M, Pickard AS.
JAMA. 2022 May 3;327(17):1666-1678
doi: https://doi.org/10.1001/jama.2022.4726
Effect of Self-monitoring of Blood Pressure on Blood Pressure Control in Pregnant Individuals With Chronic or Gestational Hypertension: The BUMP 2 Randomized Clinical Trial
Chappell LC, Tucker KL, Galal U, Yu LM, Campbell H, Rivero-Arias O, Allen J, Band R, Chisholm A, Crawford C, Dougall G, Engonidou L, Franssen M, Green M, Greenfield S, Hinton L, Hodgkinson J, Lavallee L, Leeson P, McCourt C, Mackillop L, Sandall J, Santos M, Tarassenko L, Velardo C, Wilson H, Yardley L, McManus RJ; BUMP 2 Investigators.
Value in Health. 2021 Sep;24(9):1343-1349
doi: https://doi.org/10.1016/j.jval.2021.02.012
To What Extent Do Patient Preferences Differ From General Population Preferences?
Ludwig K, Ramos-Goñi JM, Oppe M, Kreimeier S, Greiner W.
Medical Decision Making. 2022 Mar 7;7(1):23814683221083839
doi: https://doi.org/10.1177/23814683221083839
Sample Size and Model Prediction Accuracy in EQ-5D-5L Valuations Studies: Expected Out-of-Sample Accuracy Based on Resampling with Different Sample Sizes and Alternative Model Specifications
Hansen TM, Stavem K, Rand K.
Value in Health. 2022 Apr;25(4):482-491
doi: https://doi.org/10.1016/j.jval.2022.01.009
The EQ-HWB: Overview of the Development of a Measure of Health and Wellbeing and Key Results
Brazier J, Peasgood T, Mukuria C, Marten O, Kreimeier S, Luo N, Mulhern B, Pickard AS, Augustovski F, Greiner W, Engel L, Belizan M, Yang Z, Monteiro A, Kuharic M, Gibbons L, Ludwig K, Carlton J, Connell J, Rand S, Devlin N, Jones K, Tsuchiya A, Lovett R, Naidoo B, Rowen D, Rejon-Parrilla JC.
Social Science & Medicine. 2022 Mar;296:114653
doi: https://doi.org/10.1016/j.socscimed.2021.114653
The QALY at 50: One story many voices
Spencer A, Rivero-Arias O, Wong R, Tsuchiya A, Bleichrodt H, Edwards RT, Norman R, Lloyd A, Clarke P.
The European Journal of Health Economics . 2021 Jul;22(5):711-721
doi: https://doi.org/10.1007/s10198-021-01285-1
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses
Oppe M, Ortín-Sulbarán D, Vila Silván C, Estévez-Carrillo A, Ramos-Goñi JM.
Value in Health. 2022 Mar;25(3):451-460
doi: https://doi.org/10.1016/j.jval.2021.09.010
Investigating 5-Level EQ-5D (EQ-5D-5L) Values Based on Preferences of Patients With Heart Disease
Gandhi M, Tan RS, Lim SL, Rand K, Lam CSP, Luo N, Cheung YB.
Journal of General Internal Medicine. 2022 Dec;37(16):4103-4111
doi: https://doi.org/10.1007/s11606-022-07461-0
Pragmatic Clinical Trial to Improve Patient Experience Among Adults During Transitions from Hospital to Home: the PArTNER study
LaBedz SL, Prieto-Centurion V, Mutso A, Basu S, Bracken NE, Calhoun EA, DiDomenico RJ, Joo M, Pickard AS, Pittendrigh B, Williams MV, Illendula S, Krishnan JA.
Health and Quality of Life Outcomes. 2021 Sep 23;19(1):222
doi: https://doi.org/10.1186/s12955-021-01858-x
Valuing child and adolescent health: a qualitative study on different perspectives and priorities taken by the adult general public
Powell PA, Rowen D, Rivero-Arias O, Tsuchiya A, Brazier JE.
Pharmacoeconomics. 2022 Dec;40(Suppl 2):169-180
doi: https://doi.org/10.1007/s40273-022-01187-x
An EQ-5D-Y-3L Value Set for Belgium
Dewilde S, Roudijk B, Tollenaar NH, Ramos-Goñi JM.
Value in Health. 2022 Nov 11;S1098-3015(22)04731-3
doi: https://doi.org/10.1016/j.jval.2022.11.001
Censoring Time Trade-off Values at 0 Versus at -1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data?
Yang Z, Rand K, Luo N.
Drugs in Context. 2022 Jan 13;11:2021-9-7
doi: https://doi.org/10.7573/dic.2021-9-7
Development of a measure of prescriber satisfaction with academic detailing: the PSAD
Monteiro AL, Smart M, Saffore CD, Lee TA, Tilton ST, Fischer MA, Pickard AS.
BMJ. 2020 Nov 25;371:m4075
doi: https://doi.org/10.1136/bmj.m4075
Gestational age and hospital admissions during childhood: population based, record linkage study in England (TIGAR study)
Coathup V, Boyle E, Carson C, Johnson S, Kurinzcuk JJ, Macfarlane A, Petrou S, Rivero-Arias O, Quigley MA.
Revista Española de de Salud Pública. 2021 Jan 26;95:e202101009
doi: -
Cost-effectiveness methods of newborn screening assessment
Valcárcel Nazco C, García Pérez L, Linertová R, Castilla I, Vallejo Torres L, Ramos Goñi JM, Labrador Cañadas V, Couce ML, Espada Sáenz-Torres M, Dulín Íñiguez E, Posada M, Imaz Iglesia I, Serrano Aguilar P.
Neurosurgery. 2021 Jan 13;88(2):252-260
doi: https://doi.org/10.1093/neuros/nyaa454
Survival, Dependency, and Health-Related Quality of Life in Patients With Ruptured Intracranial Aneurysm: 10-Year Follow-up of the United Kingdom Cohort of the International Subarachnoid Aneurysm Trial
Hua, X., A. Gray, J. Wolstenholme, P. Clarke, A.J. Molyneux, R.S.C. Kerr, A. Clarke, M. Sneade, and O. Rivero-Arias.
Quality of Life Research. 2022 Apr;31(4):1199-1207
doi: https://doi.org/10.1007/s11136-021-03026-6
Time trade-off with someone to live for: impact of having significant others on time trade-off valuations of hypothetical health states
Hansen TM, Stavem K, Rand K.
Quality of Life Research. 2022 Jan;31(1):11-23
doi: https://doi.org/10.1007/s11136-021-02922-1
Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset
Feng YS, Jiang R, Pickard AS, Kohlmann T.
Archives of Disease in Childhood: Fetal & Neonatal. 2021 Mar;106(2):143-148
doi: https://doi.org/10.1136/archdischild-2020-318806
Economic evaluation of computerised interpretation of fetal heart rate during labour: a cost-consequence analysis alongside the INFANT study.
Schroeder, E., M. Yang, P. Brocklehurst, L. Linsell, and O. Rivero-Arias.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. 2021 Oct 18;29(1):153
doi: https://doi.org/10.1186/s13049-021-00967-2
A retrospective survey study of paramedic students' exposure to SARS-CoV-2, participation in the COVID-19 pandemic response, and health-related quality of life
Häikiö K, Andersen JV, Bakkerud M, Christiansen CR, Rand K, Staff T.
The European Journal of Health Economics . 2021 Nov;22(8):1301-1309
doi: https://doi.org/0.1007/s10198-021-01337-6
Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms
Shah KK, Bennett B, Lenny A, Longworth L, Brazier JE, Oppe M, Pickard AS, Shaw JW.
The Patient - Patient-Centered Outcomes Research . 2022 Mar;15(2):187-196
doi: https://doi.org/10.1007/s40271-021-00541-z
Preference Paths and Their Kaizen Tasks for Small Samples
Craig BM, Rand K, Hartman JD.
Value in Health. 2021 Jun;24(6):862-873
doi: https://doi.org/10.1016/j.jval.2021.01.007
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
King MT, Norman R, Mercieca-Bebber R, Costa DSJ, McTaggart-Cowan H, Peacock S, Janda M, Müller F, Viney R, Pickard AS, Cella D; Multi-Attribute Utility in Cancer Consortium.
Quality of Life Research. 2022 Feb;31(2):517-526
doi: https://doi.org/10.1007/s11136-021-02938-7
Norwegian population norms for the EQ-5D-5L: results from a general population survey
Garratt AM, Hansen TM, Augestad LA, Rand K, Stavem K.
The European Journal of Health Economics . 2021 Dec;22(9):1467-1475
doi: https://doi.org/10.1007/s10198-021-01326-9
General population normative data for the EQ-5D-3L in the five largest European economies
Janssen MF, Pickard AS, Shaw JW.
Frontiers in Psychology. 2021 Jun 21;12:588478
doi: https://doi.org/10.3389/fpsyg.2021.588478
What Should I Trust? Individual Differences in Attitudes to Conflicting Information and Misinformation on COVID-19
Filkuková P, Ayton P, Rand K, Langguth J.
The European Journal of Health Economics . 2021 Jul;22(5):723-733
doi: https://doi.org/10.1007/s10198-021-01286-0
Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists
Zoratti MJ, Pickard AS, Stalmeier PFM, Ollendorf D, Lloyd A, Chan KKW, Husereau D, Brazier JE, Krahn M, Levine M, Thabane L, Xie F; Health Utility Book (HUB) Working Group.
Journal of Patient-Reported Outcomes.. 2020 Nov 9;4(1):92
doi: https://doi.org/10.1186/s41687-020-00247-0
Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L
Rand K, Arnevik EA, Walderhaug E.
Medical Decision Making. 2021 May;41(4):485-501
doi: https://doi.org/0.1177/0272989X211003569
United States Utility Algorithm for the EORTC QLU-C10D, a Multiattribute Utility Instrument Based on a Cancer-Specific Quality-of-Life Instrument
Revicki DA, King MT, Viney R, Pickard AS, Mercieca-Bebber R, Shaw JW, Müller F, Norman R.
Value in Health. 2020 Nov;23(11):1489-1496.
doi: https://doi.org/10.1016/j.jval.2020.07.006
Testing the "Nonstopping" Time Trade-Off: Is It Better Than the Composite Time Trade-Off?
Luo N, Augestad L, Rand K.
Journal of General Internal Medicine. 2021 May;36(5):1292-1301
doi: https://doi.org/10.1007/s11606-021-06674-z
A US Population Health Survey on the Impact of COVID-19 Using the EQ-5D-5L
Hay JW, Gong CL, Jiao X, Zawadzki NK, Zawadzki RS, Pickard AS, Xie F, Crawford SA, Gu NY.
Journal of Continuing Education in the Health Professions. 2020 Fall;40(4):235-241
doi: https://doi.org/10.1097/CEH.0000000000000305
Development of an Instrument to Assess the Perceived Effectiveness of Academic Detailing
Smart MH, Monteiro AL, Saffore CD, Ruseva A, Lee TA, Fischer MA, Pickard AS.
Value in Health. 2020 Nov;23(11):1489-1496
doi: https://doi.org/10.1016/j.jval.2020.07.006
Testing the "Nonstopping" Time Trade-Off: Is It Better Than the Composite Time Trade-Off?
Luo N, Augestad L, Rand K.
Journal of Patient-Reported Outcomes. 2020 Nov 9;4(1):92
doi: https://doi.org/10.1186/s41687-020-00247-0
Quality of life among patients seeking treatment for substance use disorder, as measured with the EQ-5D-3L
Rand K, Arnevik EA, Walderhaug E.
Value in Health. 2020 Apr;23(4):487-494
doi: https://doi.org/10.1016/j.jval.2019.10.003
Using the Choice Sequence in Time Trade-Off as Discrete Choices: Do the Two Stories Match?
Augestad LA, Rand K, Luo N, Barra M.
BMC Health Services Research. 2019 Oct 16;19(1):705
doi: https://doi.org/10.1186/s12913-019-4538-7
Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010-2015
Rand K, Dahl FA, Viana J, Rønning OM, Faiz KW, Barra M.
PharmacoEconomics. 2019 May;37(5):715-725
doi: https://doi.org/10.1007/s40273-018-0758-7
EQ-5D-5L Valuation for the Malaysian Population
Shafie AA, Vasan Thakumar A, Lim CJ, Luo N, Rand-Hendriksen K, Md Yusof FA.
Quality of Life Research. 2019 May;28(5):1129-1143
doi: https://doi.org/10.1007/s11136-018-2043-9
A Norwegian 15D value algorithm: proposing a new procedure to estimate 15D value algorithms
Michel YA, Augestad LA, Barra M, Rand K.
Journal of Neurology. 2019 Jan;266(1):68-84
doi: https://doi.org/10.1007/s00415-018-9102-6
Stroke incidence in the young: evidence from a Norwegian register study
Barra M, Labberton AS, Faiz KW, Lindstrøm JC, Rønning OM, Viana J, Dahl FA, Rand K.
Value in Health. 2019 Jan;22(1):23-30
doi: https://doi.org/10.1016/j.jval.2018.05.010
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol
Stolk E, Ludwig K, Rand K, van Hout B, Ramos-Goñi JM.
Substance Abuse: Research and Treatment. 2019 Aug 15;13:1178221819866181
doi: https://doi.org/10.1177/1178221819866181
Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst
Brorson HH, Arnevik EA, Rand K.
Value in Health. 2018 Sep;21(9):1124-1131
doi: https://doi.org/10.1016/j.jval.2018.02.004
Quality-Adjusted Life-Years without Constant Proportionality
Craig BM, Rand K, Bailey H, Stalmeier PFM.
Value in Health. 2018 Apr;21(4):462-470
doi: https://doi.org/10.1016/j.jval.2017.09.018
Comparing 15D Valuation Studies in Norway and Finland-Challenges When Combining Information from Several Valuation Tasks
Michel YA, Augestad LA, Rand K.
Value in Health. 2017 Jul-Aug;20(7):945-952
doi: https://doi.org/10.1016/j.jval.2017.03.013
Less Is More: Cross-Validation Testing of Simplified Nonlinear Regression Model Specifications for EQ-5D-5L Health State Values
Rand-Hendriksen K, Ramos-Goñi JM, Augestad LA, Luo N.
Quality of Life Research. 2017 Dec;26(12):3353-3363
doi: https://doi.org/10.1007/s11136-017-1683-5
Comparison of health state values derived from patients and individuals from the general population
Gandhi M, Tan RS, Ng R, Choo SP, Chia WK, Toh CK, Lam C, Lee PT, Latt NKZ, Rand-Hendriksen K, Cheung YB, Luo N.
Value in Health. 2017 Apr;20(4):662-669
doi: https://doi.org/10.1016/j.jval.2016.11.016
Estimating an EQ-5D-5L Value Set for China
Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K.
Quality of Life Research. 2016 Sep;25(9):2179-91
doi: https://doi.org/10.1007/s11136-016-1266-x
Influenced from the start: anchoring bias in time trade-off valuations
Augestad LA, Stavem K, Kristiansen IS, Samuelsen CH, Rand-Hendriksen K.
Health and Quality of Life Outcomes. 2016 Nov 28;14(1):164
doi: https://doi.org/10.1186/s12955-016-0565-9
"When I saw walking I just kind of took it as wheeling": interpretations of mobility-related items in generic, preference-based health state instruments in the context of spinal cord injury
Michel YA, Engel L, Rand-Hendriksen K, Augestad LA, Whitehurst DG.
Value in Health. 2015 Mar;18(2):217-23
doi: https://doi.org/10.1016/j.jval.2014.11.005
Learning and satisficing: an analysis of sequence effects in health valuation
Craig BM, Runge SK, Rand-Hendriksen K, Ramos-Goñi JM, Oppe M.
Quality of Life Research. 2013 May;22(4):705-14
doi: https://doi.org/10.1007/s11136-012-0192-9
Time trade-off and attitudes toward euthanasia: implications of using 'death' as an anchor in health state valuation
Augestad LA, Rand-Hendriksen K, Stavem K, Kristiansen IS.
Clinical Psychology Review. 2013 Dec;33(8):1010-24
doi: https://doi.org/10.1016/j.cpr.2013.07.007
Drop-out from addiction treatment: a systematic review of risk factors
Brorson HH, Ajo Arnevik E, Rand-Hendriksen K, Duckert F.
Value in Health. 2012 Jul-Aug;15(5):777-82
doi: https://doi.org/10.1016/j.jval.2012.04.002
Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states
Rand-Hendriksen K, Augestad LA.
Quality of Life Research. 2012 Aug;21(6):1005-12
doi: https://doi.org/10.1007/s11136-011-0016-3
Comparison of hypothetical and experienced EQ-5D valuations: relative weights of the five dimensions
Rand-Hendriksen K, Augestad LA, Kristiansen IS, Stavem K.
Quality of Life Research. 2020 Oct 6
doi: https://doi.org/10.1007/s11136-020-02650-y
US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
Jiang R, Janssen MFB, Pickard AS.
Quality of Life Research. 2020 Nov 28
doi: https://doi.org/10.1007/s11136-020-02712-1
Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off
Jiang R, Shaw J, Mühlbacher A, Lee TA, Walton S, Kohlmann T, Norman R, Pickard AS.
Quality of Life Research. 2020 Oct;29(10):2651-2660
doi: https://doi.org/10.1007/s11136-020-02520-7
Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings
Joseph RW, Liu FX, Shillington AC, Macahilig CP, Diede SJ, Dave V, Harshaw Q, Saretsky TL, Pickard AS.
Value in Health. 2019 Mar;22(3):267-275
doi: https://doi.org/10.1016/j.jval.2019.01.004
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
Brazier J, Ara R, Azzabi I, Busschbach J, Chevrou-Séverac H, Crawford B. Cruz L, Karnon J, Lloyd A. Paisley S, Pickard AS.
Pediatric Pulmonology. 2019 Feb;54(2):179-185
doi: https://doi.org/10.1002/ppul.24203
Health outcomes in spinal muscular atrophy type 1 following AVXS-101 gene replacement therapy
Al-Zaidy S, Pickard AS, Kotha K, Alfano LN, Lowes L, Paul G, Church K, Lehman K, Sproule DM, Dabbous O, Maru B, Berry K, Arnold WD, Kissel JT, Mendell JR, Shell R.
Journal of Patient-Reported Outcomes. 2017;2(1):13
doi: https://doi.org/10.1186/s41687-018-0032-y
Value of transfusion independence in severe aplastic anemia from patients' perspectives - a discrete choice experiment
Pickard AS, Huynh L, Ivanova JI, Totev T, Graham S, Mühlbacher AC, Roy A, Duh MS.
Journal of Comparative Effectiveness Research. 2018 Feb;7(2):177-180
doi: https://doi.org/10.2217/cer-2017-0057
Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers
Schumock GT, Pickard AS.
PharmacoEconomics. 2018 Jun;36(6):637-640
doi: https://doi.org/10.1007/s40273-018-0622-9
3L, 5L, What the L? A NICE Conundrum
Devlin N, Brazier J, Pickard AS, Stolk E.
Medical Care. 2017 Nov;55(11):979-984
doi: https://doi.org/10.1097/MLR.0000000000000802
Patient Experience-based Value Sets: Are They Stable?
Pickard AS, Hung YT, Lin FJ, Lee TA.
PLoS One. 2017 May 30;12(5):e0177323
doi: https://doi.org/10.1371/journal.pone.0177323
The societal cost of heroin use disorder in the United States
Jiang R, Lee I, Lee TA, Pickard AS.
Journal of Medical Economics. 2017 Jan;20(1):19-27
doi: https://doi.org/10.1080/13696998.2016.1219359
EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis
Pickard AS, Gooderham M, Hartz S, Nicolay C.
Quality of Life Research. 2016 Mar;25(3):625-36
doi: https://doi.org/10.1007/s11136-015-1217-y
QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
King MT, Costa DS, Aaronson NK, Brazier JE, Cella DF, Fayers PM, Grimison P, Janda M, Kemmler G, Norman R, Pickard AS, Rowen D, Velikova G, Young TA, Viney R.
PharmacoEconomics. 2015 Aug;33(8):867-77
doi: https://doi.org/10.1007/s40273-015-0292-9
A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)
Xie F, Pickard AS, Krabbe PF, Revicki D, Viney R, Devlin N, Feeny D.
Journal of Managed Care & Specialty Pharmacy. 2015 Feb;21(2):114-22
doi: https://doi.org/10.18553/jmcp.2015.21.2.114
Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors
Ursan ID, Jiang R, Pickard EM, Lee TA, Ng D, Pickard AS.
Journal of Comparative Effectiveness Research. 2015;4(4):359-66
doi: https://doi.org/10.2217/cer.15.14
Using linked electronic data to validate algorithms for health outcomes in administrative databases
Lee WJ, Lee TA, Pickard AS, Shoaibi A, Schumock GT.
Value in Health. 2012 Jul;15(5):708-15
doi: https://doi.org/10.1016/j.jval.2012.02.008
Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, Lloyd A, Scalone L, Kind P, Pickard AS.
Seminars in Arthritis and Rheumatism. 2012 Aug;42(1):56-65
doi: https://doi.org/10.1016/j.semarthrit.2011.12.005
Disease-specific patient reported outcome tools for systemic lupus erythematosus
Jolly M, Pickard AS, Block JA, Kumar RB, Mikolaitis RA, Wilke CT, Rodby RA, Fogg L, Sequeira W, Utset TO, Cash TF, Moldovan I, Katsaros E, Nicassio P, Ishimori ML, Kosinsky M, Merrill JT, Weisman MH, Wallace DJ.
European Journal of Cancer. 2012 Feb;48(3):311-323
doi: https://doi.org/10.1016/j.ejca.2011.05.017
Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomized phase III trial
Cella D, Pickard AS, Duh MS, Guerin A, Mishagina N, Antràs L, Neary MP, McCann L, Hodge R, Sternberg CN.
Health Services Research. 2011 Aug;46(4):1104-1123
doi: https://doi.org/10.1111/j.1475-6773.2011.01273.x
The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility
Liu FX, Alexander GC, Crawford SY, Pickard AS, Hedeker D, Walton SM.
Bone Marrow Transplantation. 2011 Aug;46(8):1084-8
doi: https://doi.org/10.1038/bmt.2010.254
Outcome, toxicity profile and cost analysis of autologous stem cell mobilization
Jagasia MH, Savani BN, Neff A, Dixon S, Chen H, Pickard AS.
Archives of Internal Medicine. 2009 Aug 10;169(15):1403-10
doi: https://doi.org/10.1001/archinternmed.2009.233
Outcomes Associated With Tiotropium Use in Patients With Chronic Obstructive Pulmonary Disease
Lee TA, Wilke CT, Joo M, Stroupe KT, Krishnan J, Schumock GT, Pickard AS.
Medical Care. 2009 Feb;47(2):176-83
doi: https://doi.org/10.1097/MLR.0b013e31818475f4
Proxy assessment of HRQL in African American and white respondents with prostate cancer: the importance of perspective
Pickard AS, Lin HW, Knight SJ, Hung S-Y, Chang C-H, Sharifi R, Bennett CL.
Health and Quality of Life Outcomes. 2007 Dec 21;5:70
doi: https://doi.org/10.1186/1477-7525-5-70
Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer
Pickard AS, Neary M, Cella D.
Medical Care. 2007 Sept;45(9):812-819
doi: https://doi.org/10.1097/MLR.0b013e31805371aa
Evaluating Equivalency Between Response Systems: Application of the Rasch Model to a 3-Level and 5-Level EQ-5D
Pickard AS, Kohlmann T, Janssen MF, Bonsel G, Rosenbloom S, Cella D.
The European Journal of Health Economics . 2014 Dec;15(9):917-25
doi: https://doi.org/10.1007/s10198-013-0534-8
Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
Hidalgo-Vega A, Ramos-Goñi JM, Villoro R.
BMC Musculoskeletal Disorders . 2011 Dec 21;12:287
doi: https://doi.org/10.1186/1471-2474-12-287
Avoidable costs of physical treatments for chronic back, neck and shoulder pain within the Spanish National Health Service: a cross-sectional study
Serrano-Aguilar P, Kovacs FM, Cabrera-Hernández JM, Ramos-Goñi JM, García-Pérez L.
Obesity Surgery. 2014 Dec;24(12):2061-8
doi: https://doi.org/10.1007/s11695-014-1304-0
Cost-Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain
Castilla I, Mar J, Valcárcel-Nazco C, Arrospide A, Ramos-Goñi JM.
The Stata Journal. 2016;16(3):691-701
doi: NA
eq5dds: A command to analyze the descriptive system of EQ-5D quality-of-life instrument
Ramos-Goñi JM, Ramallo-Fariña Y.
Value in Health. 2018 Feb;21(2):229-238
doi: https://doi.org/10.1016/j.jval.2017.09.016
Choice Defines Value: A Predictive Modeling Competition in Health Preference Research
Jakubczyk M, Craig BM, Barra M, Groothuis-Oudshoorn CGM, Hartman JD, Huynh E, Ramos-Goñi JM, Stolk EA, Rand K.
Health Policy. 2019; Vol 123(2): 152-158
doi: https://doi.org/10.1016/j.healthpol.2018.11.015
Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?
Lopez-Bastida J, Ramos-Goni JM, Aranda-Reneo I, Trapero-Bertran M, Kanavos P, Rodriguez Martin B.
Gaceta Sanitaria. 2020 Jan-Feb;34(1):91-95
doi: https://doi.org/10.1016/j.gaceta.2018.09.003
Application of two-part models and Cholesky decomposition to incorporate covariate-adjusted utilities in probabilistic cost-effectiveness models
Arrospide A, Ramos-Goñi JM, Pechlivanoglou P, Mar J.
The Patient - Patient-Centered Outcomes Research . 2020 Jun;13(3):317-325
doi: https://doi.org/10.1007/s40271-019-00407-5
A Qualitative Research for Defining Meaningful Attributes for the Treatment of Inflammatory Bowel Disease from the Patient Perspective
Louis E, Ramos-Goni JM, Cuervo J, Kopylov U, Barreiro-de Acosta M, McCartney S, Rosenfeld G, Bettenworth D, Hart A, Novak K, Donnet X, Easton D, Saldana R, Protze K, Tzur E, Alperovich G, Casellas F.
PharmacoEconomics. 2015 Oct;33(10):985-91
doi: https://doi.org/10.1007/s40273-015-0319-2
Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.
Value in Health. 2017 Mar;20(3):466-473
doi: https://doi.org/10.1016/j.jval.2016.10.012
Quality Control Process for EQ-5D-5L Valuation Studies
Ramos-Goñi JM, Oppe M, Slaap B, Busschbach JJ, Stolk E.
Medical Decision Making. 2006;26(1):18-29
doi: https://doi.org/10.1177/0272989X05284108
Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping
Gray AM, Rivero-Arias O, Clarke PM.
Medical Decision Making. 2010;30(3):341-54
doi: https://doi.org/10.1177/0272989X09349961
Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome
Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R.
Value in Health. 2009;13(1):34-41
doi: https://doi.org/10.1111/j.1524-4733.2009.00582.x
The multinational nature of cost-effectiveness analyses alongside multinational clinical trials
Rivero-Arias O, Gray A.
American Journal of Medical Genetics Part A. 2014;164(7):1648-58
doi: https://doi.org/10.1002/ajmg.a.36511
Epidemiology of fragile X syndrome: a systematic review and meta-analysis
Hunter J, Rivero-Arias O, Angelov A, Kim E, Fotheringham I, Leal J.
PharmacoEconomics. 2014;32(7):693-706
doi: https://doi.org/10.1007/s40273-014-0153-y
Mapping EQ-5D utility scores from the PedsQL generic core scales
Khan KA, Petrou S, Rivero-Arias O, Walters SJ, Boyle SE.
PharmacoEconomics. 2015;33(10):993-1011
doi: https://doi.org/10.1007/s40273-015-0312-9
The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration
Petrou S, Rivero-Arias O, Dakin H, Longworth L, Oppe M, Froud R, Gray A.
Medical Care. 2017;55(7):e51-e8
doi: https://doi.org/10.1097/MLR.0000000000000283
Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach
Ramos-Goni JM, Pinto-Prades JL, Oppe M, Cabases JM, Serrano-Aguilar P, Rivero-Arias O.
Value in Health. 2018;21(5):596-604
doi: https://doi.org/10.1016/j.jval.2017.10.023
Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression Approach
Ramos-Goñi JM, Craig BM, Oppe M, Ramallo-Fariña Y, Pinto-Prades JL, Luo N, Rivero-Arias O.
The Patient - Patient-Centered Outcomes Research . 2018;11(2):235-47
doi: https://doi.org/10.1007/s40271-017-0278-0
Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong
Wong ELY, Ramos-Goni JM, Cheung AWL, Wong AYK, Rivero-Arias O.
British Journal of General Practice. 2019;69(686):e629-e37
doi: https://doi.org/10.3399/bjgp19X705101
Patient preferences for management of high blood pressure in the UK: a discrete choice experiment
Fletcher B, Hinton L, McManus R, Rivero-Arias O.
PloS One. 2019;14(4):e0215098
doi: https://doi.org/10.1371/journal.pone.0215098
Exploring women's preferences for birth settings in England: A discrete choice experiment
Fletcher BR, Rowe R, Hollowell J, Scanlon M, Hinton L, Rivero-Arias O.
Health Expectations. 2020 Feb;23(1):202-11
doi: https://doi.org/10.1111/hex.12992
Preferences for interventions designed to increase cervical screening uptake in non-attending young women: How findings from a discrete choice experiment compare with observed behaviours in a trial
Campbell HE, Gray AM, Watson J, Jackson C, Moseley C, Cruickshank ME, Kitchener HC, Rivero-Arias O.
PharmacoEconomics. 2020 May;38(5):499-513
doi: https://doi.org/10.1007/s40273-020-00884-9
Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling
Dalziel K, Catchpool M, Garcia-Lorenzo B, Gorostiza I, Norman R, Rivero-Arias O.
Internal Medicine Journal. 2020 Dec;50(12):1538-46
doi: https://doi.org/10.1111/imj.14942
Scoring system to facilitate diagnosis of Gaucher disease
Mehta A, Rivero-Arias O, Abdelwahab M, Campbell S, McMillan A, Rolfe MJ, Bright JR, Kuter DJ.
PharmacoEconomics. 2016 Oct;34(10):993-1004
doi: https://doi.org/10.1007/s40273-016-0404-1
EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
Oppe M, Rand-Hendriksen K, Shah K, Ramos-Goñi JM, Luo N.
Value in Health. 2019 Aug;22(8):931-941
doi: https://doi.org/10.1016/j.jval.2019.02.009
United States Valuation of EQ-5D-5L Health States Using an International Protocol
Pickard AS, Law EH, Jiang R, Pullenayegum E, Shaw JW, Xie F, Oppe M, Boye KS, Chapman RH, Gong CL, Balch A, Busschbach JJV.
The Stata Journal. Volume 13 Number 3: pp. 474-491
doi: NA
Response mapping to translate health outcomes into the generic health-related quality-of-life instrument EQ-5D: Introducing the mrs2eq and oks2eq commands
Ramos-Goñi JM, Rivero-Arias O, Dakin H.
PharmacoEconomics. 2020 Jul;38(7):653-663
doi: https://doi.org/10.1007/s40273-020-00909-3
International Valuation Protocol for the EQ-5D-Y-3L
Ramos-Goñi JM, Oppe M, Stolk E, Shah K, Kreimeier S, Rivero-Arias O, Devlin N.
The Stata Journal. Volume 11 Number 1: pp. 120-125
doi: NA
eq5d: A command to calculate index values for the EQ-5D quality-of-life instrument
Ramos-Goñi JM, Rivero-Arias O.
